← Back to Clinical Trials
Recruiting NCT06380504

NCT06380504 Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06380504
Status Recruiting
Phase —
Sponsor International Food Policy Research Institute
Condition Acute Malnutrition, Severe
Study Type INTERVENTIONAL
Enrollment 1,080 participants
Start Date 2024-05-02
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 6 Months
Max Age 5 Years
Study Type INTERVENTIONAL
Interventions
R-SWITCH integrated intervention package

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,080 participants in total. It began in 2024-05-02 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The R-SWITCH intervention aims to address the low coverage of treatment for severe wasting (SAM) by leveraging existing community groups to deliver an integrated package focused on prevention, screening, referral, and treatment of SAM. It includes behavior change communication on child nutrition and health, active screening, improved passive screening at health posts, and follow-up of referred cases and those enrolled in outpatient treatment programs (OTP). The primary objectives of the R-SWITCH studies are to assess the intervention's impact on OTP coverage, identify implementation barriers and facilitators, and evaluate its cost-efficiency and cost-effectiveness.

Eligibility Criteria

Inclusion Criteria: * Child 6-59 months of age * Suffering from SAM (defined as MUAC \< 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score \<-3) OR currently enrolled in SAM OTP Exclusion Criteria: \- Anthropometric malformation or being handicapped which hampers anthropometric measurements.

Contact & Investigator

Central Contact

Lieven Huybregts, PhD

✉ l.huybregts@cgiar.org

📞 202 862-6481

Principal Investigator

Lieven Huybregts, PhD

PRINCIPAL INVESTIGATOR

International Food Policy Research Institute

Frequently Asked Questions

Who can join the NCT06380504 clinical trial?

This trial is open to participants of all sexes, aged 6 Months or older, up to 5 Years, studying Acute Malnutrition, Severe. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06380504 currently recruiting?

Yes, NCT06380504 is actively recruiting participants. Contact the research team at l.huybregts@cgiar.org for enrollment information.

Where is the NCT06380504 trial being conducted?

This trial is being conducted at Jimma, Ethiopia.

Who is sponsoring the NCT06380504 clinical trial?

NCT06380504 is sponsored by International Food Policy Research Institute. The principal investigator is Lieven Huybregts, PhD at International Food Policy Research Institute. The trial plans to enroll 1,080 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology